Neuroinflammation and glutamatergic signaling (WP5083)

Homo sapiens

Authors

Lisa Koole , Friederike Ehrhart , Lauren J. Dupuis , Eric Weitz , Finterly Hu , and Egon Willighagen

Activity

Discuss this pathway

Check for ongoing discussions or start your own.

Cited In

Are you planning to include this pathway in your next publication? See How to Cite and add a link here to your paper once it's online.

Organisms

Homo sapiens

Communities

Annotations

Pathway Ontology

signaling pathway pertinent to the brain and nervous system neuropsychiatric disease pathway signaling pathway pertinent to immunity

Cell Type Ontology

microglial cell neuron astrocyte

References

1. Neuroprotective strategies for NMDAR-mediated excitotoxicity in Huntington’s Disease. Girling KD, Wang YT. Front Biol [Internet]. 2016 Nov 17;11(6):439–58. Available from: http://dx.doi.org/10.1007/s11515-016-1425-z DOI Scholia
2. The human blood-brain barrier glucose transporter (GLUT1) is a glucose transporter of gray matter astrocytes. Morgello S, Uson RR, Schwartz EJ, Haber RS. Glia. 1995 May;14(1):43–54. PubMed Europe PMC Scholia
3. Alteration of second messengers during acute cerebral ischemia - adenylate cyclase, cyclic AMP-dependent protein kinase, and cyclic AMP response element binding protein. Tanaka K. Prog Neurobiol. 2001 Oct;65(2):173–207. PubMed Europe PMC Scholia
4. How calcium inhibits the magnesium-dependent enzyme human phosphoserine phosphatase. Peeraer Y, Rabijns A, Collet JF, Van Schaftingen E, De Ranter C. Eur J Biochem. 2004 Aug;271(16):3421–7. PubMed Europe PMC Scholia
5. Smads keep TABs on inflammation. Seth RB, Chen ZJ. Nat Immunol. 2007 May;8(5):477–8. PubMed Europe PMC Scholia
6. Strategies to enhance N-methyl-D-aspartate receptor-mediated neurotransmission in schizophrenia, a critical review and meta-analysis. Tsai GE, Lin PY. Curr Pharm Des. 2010;16(5):522–37. PubMed Europe PMC Scholia
7. Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Hardingham GE, Bading H. Nat Rev Neurosci. 2010 Oct;11(10):682–96. PubMed Europe PMC Scholia
8. Long-term potentiation and long-term depression: a clinical perspective. Bliss TVP, Cooke SF. Clinics (Sao Paulo). 2011;66 Suppl 1(Suppl 1):3–17. PubMed Europe PMC Scholia
9. Metal toxicity at the synapse: presynaptic, postsynaptic, and long-term effects. Sadiq S, Ghazala Z, Chowdhury A, Büsselberg D. J Toxicol. 2012;2012:132671. PubMed Europe PMC Scholia
10. IL-4 in the brain: a cytokine to remember. Gadani SP, Cronk JC, Norris GT, Kipnis J. J Immunol. 2012 Nov 1;189(9):4213–9. PubMed Europe PMC Scholia
11. D-serine as a gliotransmitter and its roles in brain development and disease. Van Horn MR, Sild M, Ruthazer ES. Front Cell Neurosci. 2013 Apr 23;7:39. PubMed Europe PMC Scholia
12. Metabotropic glutamate receptors for Parkinson’s disease therapy. Gasparini F, Di Paolo T, Gomez-Mancilla B. Parkinsons Dis. 2013;2013:196028. PubMed Europe PMC Scholia
13. Extrasynaptic NMDA receptor involvement in central nervous system disorders. Parsons MP, Raymond LA. Neuron. 2014 Apr 16;82(2):279–93. PubMed Europe PMC Scholia
14. When astrocytes become harmful: functional and inflammatory responses that contribute to Alzheimer’s disease. Avila-Muñoz E, Arias C. Ageing Res Rev. 2014 Nov;18:29–40. PubMed Europe PMC Scholia
15. Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases. Tang Y, Le W. Mol Neurobiol. 2016 Mar;53(2):1181–94. PubMed Europe PMC Scholia
16. DISC1, astrocytes and neuronal maturation: a possible mechanistic link with implications for mental disorders. Xia M, Zhu S, Shevelkin A, Ross CA, Pletnikov M. J Neurochem. 2016 Aug;138(4):518–24. PubMed Europe PMC Scholia
17. Astrocytes: Key Regulators of Neuroinflammation. Colombo E, Farina C. Trends Immunol. 2016 Sep;37(9):608–20. PubMed Europe PMC Scholia
18. Role of Atypical Chemokine Receptors in Microglial Activation and Polarization. Salvi V, Sozio F, Sozzani S, Del Prete A. Front Aging Neurosci. 2017 May 26;9:148. PubMed Europe PMC Scholia
19. D-serine released by astrocytes in brainstem regulates breathing response to CO2 levels. Beltrán-Castillo S, Olivares MJ, Contreras RA, Zúñiga G, Llona I, von Bernhardi R, et al. Nat Commun. 2017 Oct 10;8(1):838. PubMed Europe PMC Scholia
20. Glutamatergic synaptic plasticity and dysfunction in Alzheimer disease: Emerging mechanisms. Benarroch EE. Neurology. 2018 Jul 17;91(3):125–32. PubMed Europe PMC Scholia
21. Astrocytic Regulation of Glutamate Transmission in Schizophrenia. Mei YY, Wu DC, Zhou N. Front Psychiatry. 2018 Nov 6;9:544. PubMed Europe PMC Scholia
22. Deleterious Alteration of Glia in the Brain of Alzheimer’s Disease. Kim E, Otgontenger U, Jamsranjav A, Kim SS. Int J Mol Sci. 2020 Sep 12;21(18):6676. PubMed Europe PMC Scholia
23. The Dual Role of Glutamatergic Neurotransmission in Alzheimer’s Disease: From Pathophysiology to Pharmacotherapy. Bukke VN, Archana M, Villani R, Romano AD, Wawrzyniak A, Balawender K, et al. Int J Mol Sci. 2020 Oct 9;21(20):7452. PubMed Europe PMC Scholia
24. The Inflamed Brain in Schizophrenia: The Convergence of Genetic and Environmental Risk Factors That Lead to Uncontrolled Neuroinflammation. Comer AL, Carrier M, Tremblay MÈ, Cruz-Martín A. Front Cell Neurosci. 2020 Aug 27;14:274. PubMed Europe PMC Scholia
25. Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes. Kwon HS, Koh SH. Transl Neurodegener. 2020 Nov 26;9(1):42. PubMed Europe PMC Scholia
26. Astrocytes: a double-edged sword in neurodegenerative diseases. Ding ZB, Song LJ, Wang Q, Kumar G, Yan YQ, Ma CG. Neural Regen Res. 2021 Sep;16(9):1702–10. PubMed Europe PMC Scholia
27. Metabolism of Amino Acids in Cancer. Wei Z, Liu X, Cheng C, Yu W, Yi P. Front Cell Dev Biol. 2021 Jan 12;8:603837. PubMed Europe PMC Scholia